{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:46:25Z","timestamp":1789055185953,"version":"build-2803163510"},"reference-count":20,"publisher":"Aging and Disease","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2020]]},"DOI":"10.14336\/ad.2020.0301","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T15:44:15Z","timestamp":1584114255000},"page":"462","source":"Crossref","is-referenced-by-count":117,"title":["Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia"],"prefix":"10.14336","volume":"11","author":[{"given":"Ashok K","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2020.0301-1","doi-asserted-by":"crossref","unstructured":"Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, et al. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis, 11:216-228.","DOI":"10.14336\/AD.2020.0228"},{"key":"key-10.14336\/AD.2020.0301-2","doi-asserted-by":"crossref","unstructured":"Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E (2020). A novel coronavirus emerging in China - key questions for impact assessment. New England Journal of Medicine, in press.","DOI":"10.1056\/NEJMp2000929"},{"key":"key-10.14336\/AD.2020.0301-3","doi-asserted-by":"crossref","unstructured":"Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. (2020). World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19). Int J Surg, pii: S1743-9191(20)30197-7.","DOI":"10.1016\/j.ijsu.2020.02.034"},{"key":"key-10.14336\/AD.2020.0301-4","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu Q, Guo D (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol, 92(4):418-423.","DOI":"10.1002\/jmv.25681"},{"key":"key-10.14336\/AD.2020.0301-5","doi-asserted-by":"crossref","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. (2020). Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395:565-574","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"key-10.14336\/AD.2020.0301-6","doi-asserted-by":"crossref","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, in press.","DOI":"10.1038\/s41586-020-2951-z"},{"key":"key-10.14336\/AD.2020.0301-7","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Kr\u00fcger N, M\u00fcller M, Drosten C, P\u00f6hlmann S (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv:2020.2001.2031.929042.","DOI":"10.1101\/2020.01.31.929042"},{"key":"key-10.14336\/AD.2020.0301-8","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Patho, 203:631-637.","DOI":"10.1002\/path.1570"},{"key":"key-10.14336\/AD.2020.0301-9","doi-asserted-by":"crossref","unstructured":"Fauci AS, Lane HC, Redfield RR (2020). Covid-19 - Navigating the uncharted. N Engl J Med. Feb 28.","DOI":"10.1056\/NEJMe2002387"},{"key":"key-10.14336\/AD.2020.0301-10","doi-asserted-by":"crossref","unstructured":"Prockop DJ, Oh JY (2012). Mesenchymal stem\/stromal cells (MSCs): role as guardians of inflammation. Mol Ther, 20:14-20.","DOI":"10.1038\/mt.2011.211"},{"key":"key-10.14336\/AD.2020.0301-11","doi-asserted-by":"crossref","unstructured":"Prockop DJ (2017). The exciting prospects of new therapies with mesenchymal stromal cells. Cytotherapy, 19:1-8.","DOI":"10.1016\/j.jcyt.2016.09.008"},{"key":"key-10.14336\/AD.2020.0301-12","doi-asserted-by":"crossref","unstructured":"Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, et al. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurology, 11:150-156","DOI":"10.1016\/S1474-4422(11)70305-2"},{"key":"key-10.14336\/AD.2020.0301-13","doi-asserted-by":"crossref","unstructured":"Wilson JG, Liu KD, Zhuo NJ, Caballero L, McMillan M, Fang XH, et al. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respiratory Medicine, 3:24-32.","DOI":"10.1016\/S2213-2600(14)70291-7"},{"key":"key-10.14336\/AD.2020.0301-14","doi-asserted-by":"crossref","unstructured":"Hashmi S, Ahmed M, Murad MH, Litzow MR, Adams RH, Ball LM, et al. (2016). Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. Lancet Haematology, 3:E45-E52.","DOI":"10.1016\/S2352-3026(15)00224-0"},{"key":"key-10.14336\/AD.2020.0301-15","doi-asserted-by":"crossref","unstructured":"Kamen DL, Nietert PJ, Wang H, Duke T, Cloud C, Robinson A, et al. (2018). CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study. Lupus Science & Medicine, 5:A46-A47.","DOI":"10.1136\/lupus-2018-lsm.76"},{"key":"key-10.14336\/AD.2020.0301-16","doi-asserted-by":"crossref","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BLet al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 5:54-63.","DOI":"10.1016\/j.stem.2009.05.003"},{"key":"key-10.14336\/AD.2020.0301-17","doi-asserted-by":"crossref","unstructured":"Shetty AK, Upadhya R, Madhu LN, Kodali M (2019). Novel Insights on Systemic and Brain Aging, Stroke, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease. Aging Dis, 10:470-482.","DOI":"10.14336\/AD.2019.0330"},{"key":"key-10.14336\/AD.2020.0301-18","doi-asserted-by":"crossref","unstructured":"Shetty AK, Kodali M, Upadhya R, Madhu LN (2018). Emerging Anti-Aging Strategies - Scientific Basis and Efficacy. Aging Dis, 9:1165-1184.","DOI":"10.14336\/AD.2018.1026"},{"key":"key-10.14336\/AD.2020.0301-19","doi-asserted-by":"crossref","unstructured":"Thomas R, Wang W, Su DM (2020). Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging. Immun Ageing, 17:2.","DOI":"10.1186\/s12979-020-0173-8"},{"key":"key-10.14336\/AD.2020.0301-20","doi-asserted-by":"crossref","unstructured":"Oh SJ, Lee JK, Shin OS (2019). Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity. Immune Network, 19:e37.","DOI":"10.4110\/in.2019.19.e37"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-0-2003011854-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T03:33:33Z","timestamp":1627529613000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2020.0301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2020.0301","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}